MX9805870A - - Google Patents
Info
- Publication number
- MX9805870A MX9805870A MX9805870A MX9805870A MX9805870A MX 9805870 A MX9805870 A MX 9805870A MX 9805870 A MX9805870 A MX 9805870A MX 9805870 A MX9805870 A MX 9805870A MX 9805870 A MX9805870 A MX 9805870A
- Authority
- MX
- Mexico
- Prior art keywords
- enantiomers
- resolving agent
- acid
- threo
- resolution
- Prior art date
Links
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- DUGOZIWVEXMGBE-UHFFFAOYSA-N Methylphenidate Chemical compound C=1C=CC=CC=1C(C(=O)OC)C1CCCCN1 DUGOZIWVEXMGBE-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000000356 contaminant Substances 0.000 abstract 1
- 229960001344 methylphenidate Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- INGSNVSERUZOAK-UHFFFAOYSA-N ritalinic acid Chemical compound C=1C=CC=CC=1C(C(=O)O)C1CCCCN1 INGSNVSERUZOAK-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/0004—Crystallisation cooling by heat exchange
- B01D9/0013—Crystallisation cooling by heat exchange by indirect heat exchange
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Thermal Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9601228.1A GB9601228D0 (en) | 1996-01-22 | 1996-01-22 | Resolution |
| GB9700156 | 1997-01-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9805870A true MX9805870A (cg-RX-API-DMAC7.html) | 1999-01-31 |
Family
ID=26308503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9805870A MX9805870A (cg-RX-API-DMAC7.html) | 1996-01-22 | 1997-01-20 |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0883608B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4163748B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR19990081891A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE373640T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU716570B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2242595A1 (cg-RX-API-DMAC7.html) |
| CZ (1) | CZ225198A3 (cg-RX-API-DMAC7.html) |
| DE (1) | DE69738154T2 (cg-RX-API-DMAC7.html) |
| HU (1) | HUP9900798A3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX9805870A (cg-RX-API-DMAC7.html) |
| SK (1) | SK98098A3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1997027176A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5837284A (en) | 1995-12-04 | 1998-11-17 | Mehta; Atul M. | Delivery of multiple doses of medications |
| US6486177B2 (en) | 1995-12-04 | 2002-11-26 | Celgene Corporation | Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate |
| JP2000504008A (ja) * | 1996-02-02 | 2000-04-04 | メデバ・ユアラプ・リミテッド | Ｄ―トレオ―（ｒ，ｒ）―メチルフェニデートの調製およびエピメリゼーションによる不要エナンチオマーリサイクルの方法 |
| US6962997B1 (en) | 1997-05-22 | 2005-11-08 | Celgene Corporation | Process and intermediates for resolving piperidyl acetamide steroisomers |
| US6100401A (en) * | 1998-04-20 | 2000-08-08 | Novartris Ag | Process for preparing the d-threo isomer of methylphenidate hydrochloride |
| US6162919A (en) * | 1998-12-03 | 2000-12-19 | Novartis Ag | Process for preparing the d-threo isomer of methylphenidate hydrochloride |
| US6025502A (en) * | 1999-03-19 | 2000-02-15 | The Trustees Of The University Of Pennsylvania | Enantopselective synthesis of methyl phenidate |
| GB9913458D0 (en) * | 1999-06-09 | 1999-08-11 | Medeva Europ Ltd | The therapeutic use of d-threo-methylphenidate |
| WO2001043730A2 (en) * | 1999-12-17 | 2001-06-21 | Medeva Europe Limited | The treatment of convulsive states |
| WO2003031411A2 (en) * | 2001-10-12 | 2003-04-17 | Sention, Inc. | Direct resolution of racemic threo-methylphenidate hydrochloride |
| FR2853650B1 (fr) * | 2003-04-10 | 2006-07-07 | Merck Sante Sas | Procede de dedoublement d'amines utiles pour le traitement de desordres associes au syndrome d'insulino-resistance |
| US7229557B2 (en) | 2004-02-04 | 2007-06-12 | Konec, Inc. | Method to separate stereoisomers |
| US7897777B2 (en) * | 2007-01-05 | 2011-03-01 | Archimica, Inc. | Process of enantiomeric resolution of D,L-(±)-threo-methylphenidate |
| WO2010128517A1 (en) | 2009-05-07 | 2010-11-11 | Malladi Drugs & Pharmaceuticals Ltd. | Improved process for the preparation of d-threo-ritalinic acid hydrochloride by resolution of dl-threo-ritalinic acid using chiral carboxylic acid |
| US9283214B2 (en) | 2011-03-23 | 2016-03-15 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
| US11241391B2 (en) | 2011-03-23 | 2022-02-08 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
| US8916588B2 (en) | 2011-03-23 | 2014-12-23 | Ironshore Pharmaceuticals & Development, Inc. | Methods for treatment of attention deficit hyperactivity disorder |
| US9498447B2 (en) | 2011-03-23 | 2016-11-22 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
| US9119809B2 (en) | 2011-03-23 | 2015-09-01 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
| US10905652B2 (en) | 2011-03-23 | 2021-02-02 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
| EP4316488A3 (en) | 2011-03-23 | 2024-02-28 | Ironshore Pharmaceuticals & Development, Inc. | Methods and compositions for treatment of attention deficit disorder |
| US8927010B2 (en) | 2011-03-23 | 2015-01-06 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
| US9603809B2 (en) | 2011-03-23 | 2017-03-28 | Ironshore Pharmaceuticals & Development, Inc. | Methods of treatment of attention deficit hyperactivity disorder |
| US10292937B2 (en) | 2011-03-23 | 2019-05-21 | Ironshore Pharmaceuticals & Development, Inc. | Methods of treatment of attention deficit hyperactivity disorder |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2957880A (en) * | 1953-12-23 | 1960-10-25 | Ciba Pharm Prod Inc | Process for the conversion of stereoisomers |
| JPH07247286A (ja) * | 1994-01-18 | 1995-09-26 | Sankyo Co Ltd | 含窒素環状化合物の光学分割方法 |
| CN1229346C (zh) * | 1994-05-16 | 2005-11-30 | 默里尔药物公司 | 丁苯哌丁醇的非对映体盐 |
-
1997
- 1997-01-20 MX MX9805870A patent/MX9805870A/es active IP Right Grant
- 1997-01-22 CA CA002242595A patent/CA2242595A1/en not_active Abandoned
- 1997-01-22 SK SK980-98A patent/SK98098A3/sk unknown
- 1997-01-22 CZ CZ982251A patent/CZ225198A3/cs unknown
- 1997-01-22 HU HU9900798A patent/HUP9900798A3/hu not_active Application Discontinuation
- 1997-01-22 JP JP52664997A patent/JP4163748B2/ja not_active Expired - Fee Related
- 1997-01-22 KR KR1019980705603A patent/KR19990081891A/ko not_active Ceased
- 1997-01-22 DE DE69738154T patent/DE69738154T2/de not_active Expired - Fee Related
- 1997-01-22 WO PCT/GB1997/000185 patent/WO1997027176A1/en not_active Ceased
- 1997-01-22 AT AT97901158T patent/ATE373640T1/de not_active IP Right Cessation
- 1997-01-22 EP EP97901158A patent/EP0883608B1/en not_active Expired - Lifetime
- 1997-01-22 AU AU14503/97A patent/AU716570B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP0883608B1 (en) | 2007-09-19 |
| AU716570B2 (en) | 2000-03-02 |
| JP2000517288A (ja) | 2000-12-26 |
| SK98098A3 (en) | 1999-03-12 |
| DE69738154D1 (de) | 2007-10-31 |
| HUP9900798A3 (en) | 1999-11-29 |
| CZ225198A3 (cs) | 1998-12-16 |
| KR19990081891A (ko) | 1999-11-15 |
| DE69738154T2 (de) | 2008-06-12 |
| HUP9900798A2 (hu) | 1999-07-28 |
| ATE373640T1 (de) | 2007-10-15 |
| EP0883608A1 (en) | 1998-12-16 |
| WO1997027176A1 (en) | 1997-07-31 |
| CA2242595A1 (en) | 1997-07-31 |
| JP4163748B2 (ja) | 2008-10-08 |
| AU1450397A (en) | 1997-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9805870A (cg-RX-API-DMAC7.html) | ||
| BG103740A (en) | Phytostyrene composition for the prevention of the alzheimer's disease | |
| UA27224C2 (uk) | Арилалкіламіни, спосіб їх одержання та фармацевтична композиція | |
| UA66750C2 (en) | Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors | |
| SI0657428T1 (en) | Preparation of 3,4,4-trisubstitutedpiperidinyl-n-alkylcarboxylates and intermediates, useful as opioid antagonists | |
| IL115790A0 (en) | Pharmaceutical compositions containing boronic ester and acid compounds and methods for the preparation thereof | |
| MY113022A (en) | Novel pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present | |
| PL344012A1 (en) | Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them | |
| BG103485A (en) | Ketobanzamides as calpain inhibitors | |
| UA34428C2 (uk) | Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки | |
| HRP940890B1 (en) | Novel(r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benozpyranes | |
| ATE156818T1 (de) | Polyfluoralkylthiopoly(ethylimidazolium)- verbindungen, verfahren zu ihrer herstellung und ihre verwendung als biozide mittel | |
| PL311122A1 (en) | Water-solublederivatives of camptotectin, method of obtaining them and their application as anticarcinogenic agents | |
| BG101892A (en) | Sugar-modified cytostatics | |
| AU4140093A (en) | Paint stripper composition | |
| EP0956033A4 (en) | TOTAL SYNTHESIS OF THE AMINO HIP ANALOG OF DIDEMNIN A | |
| EP0460062A4 (en) | Method for the synthesis of huperzine a and analogs thereof and compounds useful therein | |
| IL137891A0 (en) | Disinfecting composition | |
| TW349000B (en) | Fungicidal two-component composition based on R-metalaxyl and usage thereof | |
| MY120683A (en) | New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals. | |
| MY120550A (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions. | |
| BG103289A (en) | Method for yohexene preparation | |
| EP0206544A3 (en) | Instantaneously curable composition | |
| AU3950095A (en) | Compositions and methods for detection of 2,4-dichlorophenoxyacetic acid and related compounds | |
| BG104373A (en) | Polymorphous forms of dofetilide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |